Could a Plant-Derived drug improve blood flow in septic shock?

NCT ID NCT07657702

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study will test a drug called anisodamine in 20 adults with septic shock who are on a ventilator. The goal is to see if the drug can improve blood flow in small blood vessels and help with a phenomenon called 'vascular waterfall.' This is a very early study to gather information for future, larger trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Anisodamine (a drug given intravenously)
What this could lead to
If this works, it could point toward a new way to improve blood flow in septic shock patients, potentially leading to better treatments.
What could go wrong
This is a very small, early pilot study with only 20 patients and no comparison group. It is designed to gather preliminary data, not to prove effectiveness. The drug may not show clear benefits or could have side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College)

    Wuhu, Anhui, 241000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.